Skip to search formSkip to main contentSkip to account menu

Thrombolysis, function

Known as: Thrombolysis, Thrombolytic 
The process of breaking up a thrombus (blood clot) that is blocking blood flow. The blood clot may be dissolved using drugs delivered through a… 
National Institutes of Health

Related topics

Related topics

2 relations
FibrinolysisFibrinolytic Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
Highly Cited
1994
Highly Cited
1994
Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina. Results of the TAUSA Trial. TAUSA Investigators. Thrombolysis and Angioplasty in Unstable Angina trial.
BACKGROUND Acute closure is increased after angioplasty in unstable angina, and adjunctive intracoronary thrombolytic therapy has… 
Highly Cited
1990
Highly Cited
1990
Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty.
Highly Cited
1990
Highly Cited
1990
Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking.
Highly Cited
1989
Highly Cited
1989
Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator.
Ischemic events after successful thrombolysis have been reported to occur in 18-32% of patients treated for acute myocardial… 
Highly Cited
1989
Highly Cited
1989
Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI…
Coagulation analysis was performed on blood samples from 386 patients with acute myocardial infarction drawn before, during, and… 
Highly Cited
1987
Highly Cited
1987
Update from the Thrombolysis in Myocardial Infarction Trial.
Highly Cited
1987
Highly Cited
1987
The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty.
Highly Cited
1984
Highly Cited
1984
Improvement of regional myocardial metabolism after coronary thrombolysis induced with tissue-type plasminogen activator or streptokinase.
To assess the effects on the heart itself of coronary thrombolysis induced with either tissue-type plasminogen activator (t-PA… 
Highly Cited
1982
Highly Cited
1982
Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis.
Extrinsic (tissue-type) plasminogen activator (plasminogen activator) was isolated either as a single-chain or as a two-chain… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)